Ahmed Abudeif, Eman Khalifa Al Sayed, Ghada Moustapha Galal
{"title":"失代偿肝硬化合并急性-慢性肝功能衰竭患者短期死亡率的特征和预测因素。","authors":"Ahmed Abudeif, Eman Khalifa Al Sayed, Ghada Moustapha Galal","doi":"10.5114/ceh.2022.122332","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim of the study: </strong>We aimed to investigate the characteristics of acute-on-chronic liver failure (ACLF) and factors associated with 28-day mortality in patients with ACLF.</p><p><strong>Material and methods: </strong>This prospective study included ACLF patients based on the European Association for the Study of the Liver-Chronic Liver Failure (EASL-CLIF) Consortium criteria, admitted between March 2021 and February 2022. We examined variables associated with 28-day mortality using multivariate Cox regression analysis.</p><p><strong>Results: </strong>Of 326 patients admitted with acute decompensation (AD) of cirrhosis, 109 (33.44%) patients were diagnosed with ACLF (mean age 63.61 ±11.15 years, 65.14% males). Of these, 26.61%, 35.78%, and 37.61% of patients were in ACLF grades 1, 2, and 3 respectively. HCV (80.73%) was the main aetiology of cirrhosis. Upper gastrointestinal bleeding (25.69%) was the most common trigger. Kidney failure (73.39%) was the most common organ failure. The 28-day mortality rate was 66.97%. Cox regression analysis revealed that the existence of 2 (HR = 6.99, 95% CI: 2.68-18.25, <i>p</i> < 0.0001) or ≥ 3 (HR = 9.34, 95% CI: 3.6-24.74, <i>p</i> < 0.0001) organ failures, hepatic encephalopathy (HR = 2.96, 95% CI: 1.27-6.94, <i>p</i> = 0.01), and elevated serum bilirubin (HR = 1.03, 95% CI: 1.00-1.06, <i>p</i> = 0.04) were independent predictors for 28-day mortality, while shifting blood pH to the normal range was associated with a decrease in the HR of ACLF mortality (HR = 0.03, 95% CI: 0.002-0.44, <i>p</i> = 0.01).</p><p><strong>Conclusions: </strong>ACLF has a very high 28-day mortality, which is associated with the existence of 2 or more organ failures, hepatic encephalopathy, elevated serum bilirubin, and low blood pH.</p>","PeriodicalId":10281,"journal":{"name":"Clinical and Experimental Hepatology","volume":"8 4","pages":"300-308"},"PeriodicalIF":1.5000,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e7/4b/CEH-8-48689.PMC9850305.pdf","citationCount":"0","resultStr":"{\"title\":\"Characteristics and predictors of short-term mortality in decompensated cirrhotic patients with acute-on-chronic liver failure.\",\"authors\":\"Ahmed Abudeif, Eman Khalifa Al Sayed, Ghada Moustapha Galal\",\"doi\":\"10.5114/ceh.2022.122332\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Aim of the study: </strong>We aimed to investigate the characteristics of acute-on-chronic liver failure (ACLF) and factors associated with 28-day mortality in patients with ACLF.</p><p><strong>Material and methods: </strong>This prospective study included ACLF patients based on the European Association for the Study of the Liver-Chronic Liver Failure (EASL-CLIF) Consortium criteria, admitted between March 2021 and February 2022. We examined variables associated with 28-day mortality using multivariate Cox regression analysis.</p><p><strong>Results: </strong>Of 326 patients admitted with acute decompensation (AD) of cirrhosis, 109 (33.44%) patients were diagnosed with ACLF (mean age 63.61 ±11.15 years, 65.14% males). Of these, 26.61%, 35.78%, and 37.61% of patients were in ACLF grades 1, 2, and 3 respectively. HCV (80.73%) was the main aetiology of cirrhosis. Upper gastrointestinal bleeding (25.69%) was the most common trigger. Kidney failure (73.39%) was the most common organ failure. The 28-day mortality rate was 66.97%. Cox regression analysis revealed that the existence of 2 (HR = 6.99, 95% CI: 2.68-18.25, <i>p</i> < 0.0001) or ≥ 3 (HR = 9.34, 95% CI: 3.6-24.74, <i>p</i> < 0.0001) organ failures, hepatic encephalopathy (HR = 2.96, 95% CI: 1.27-6.94, <i>p</i> = 0.01), and elevated serum bilirubin (HR = 1.03, 95% CI: 1.00-1.06, <i>p</i> = 0.04) were independent predictors for 28-day mortality, while shifting blood pH to the normal range was associated with a decrease in the HR of ACLF mortality (HR = 0.03, 95% CI: 0.002-0.44, <i>p</i> = 0.01).</p><p><strong>Conclusions: </strong>ACLF has a very high 28-day mortality, which is associated with the existence of 2 or more organ failures, hepatic encephalopathy, elevated serum bilirubin, and low blood pH.</p>\",\"PeriodicalId\":10281,\"journal\":{\"name\":\"Clinical and Experimental Hepatology\",\"volume\":\"8 4\",\"pages\":\"300-308\"},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2022-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e7/4b/CEH-8-48689.PMC9850305.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical and Experimental Hepatology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5114/ceh.2022.122332\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Experimental Hepatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5114/ceh.2022.122332","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
研究目的:我们旨在研究急性慢性肝衰竭(ACLF)的特征以及与ACLF患者28天死亡率相关的因素。材料和方法:这项前瞻性研究纳入了2021年3月至2022年2月期间入院的基于欧洲肝脏-慢性肝衰竭研究协会(EASL-CLIF)联盟标准的ACLF患者。我们使用多变量Cox回归分析检查了与28天死亡率相关的变量。结果:326例肝硬化急性失代偿(AD)患者中,109例(33.44%)诊断为ACLF(平均年龄63.61±11.15岁,男性65.14%)。其中,26.61%、35.78%和37.61%的患者分别为ACLF 1级、2级和3级。HCV(80.73%)是肝硬化的主要病因。上消化道出血(25.69%)是最常见的诱因。肾功能衰竭(73.39%)是最常见的器官衰竭。28天死亡率为66.97%。Cox回归分析表明,2的存在(HR = 6.99, 95%置信区间CI: 2.68 - -18.25, p < 0.0001)或≥3 (HR = 9.34, 95%置信区间CI: 3.6 - -24.74, p < 0.0001)器官衰竭,肝性脑病(HR = 2.96, 95%置信区间CI: 1.27 - -6.94, p = 0.01),和血清胆红素升高(HR = 1.03, 95%置信区间CI: 1.00 - -1.06, p = 0.04) 28天死亡率的独立预测因素,转而将血液pH值在正常范围内,减少ACLF死亡率的人力资源(HR = 0.03, 95%置信区间CI: 0.002 - -0.44, p = 0.01)。结论:ACLF具有非常高的28天死亡率,这与存在2种或2种以上器官衰竭、肝性脑病、血清胆红素升高和低血pH值有关。
Characteristics and predictors of short-term mortality in decompensated cirrhotic patients with acute-on-chronic liver failure.
Aim of the study: We aimed to investigate the characteristics of acute-on-chronic liver failure (ACLF) and factors associated with 28-day mortality in patients with ACLF.
Material and methods: This prospective study included ACLF patients based on the European Association for the Study of the Liver-Chronic Liver Failure (EASL-CLIF) Consortium criteria, admitted between March 2021 and February 2022. We examined variables associated with 28-day mortality using multivariate Cox regression analysis.
Results: Of 326 patients admitted with acute decompensation (AD) of cirrhosis, 109 (33.44%) patients were diagnosed with ACLF (mean age 63.61 ±11.15 years, 65.14% males). Of these, 26.61%, 35.78%, and 37.61% of patients were in ACLF grades 1, 2, and 3 respectively. HCV (80.73%) was the main aetiology of cirrhosis. Upper gastrointestinal bleeding (25.69%) was the most common trigger. Kidney failure (73.39%) was the most common organ failure. The 28-day mortality rate was 66.97%. Cox regression analysis revealed that the existence of 2 (HR = 6.99, 95% CI: 2.68-18.25, p < 0.0001) or ≥ 3 (HR = 9.34, 95% CI: 3.6-24.74, p < 0.0001) organ failures, hepatic encephalopathy (HR = 2.96, 95% CI: 1.27-6.94, p = 0.01), and elevated serum bilirubin (HR = 1.03, 95% CI: 1.00-1.06, p = 0.04) were independent predictors for 28-day mortality, while shifting blood pH to the normal range was associated with a decrease in the HR of ACLF mortality (HR = 0.03, 95% CI: 0.002-0.44, p = 0.01).
Conclusions: ACLF has a very high 28-day mortality, which is associated with the existence of 2 or more organ failures, hepatic encephalopathy, elevated serum bilirubin, and low blood pH.
期刊介绍:
Clinical and Experimental Hepatology – quarterly of the Polish Association for Study of Liver – is a scientific and educational, peer-reviewed journal publishing original and review papers describing clinical and basic investigations in the field of hepatology.